Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shivalik Rasayan is a prominent Indian chemical and pharmaceutical company that specializes in the production of high-potency Active Pharmaceutical Ingredients (APIs) and agrochemicals. Established in 1979, the company has transitioned from a focus on organophosphorus-based insecticides to becoming a significant manufacturer of oncology-related APIs. Their state-of-the-art manufacturing facilities in Dahej and Dehradun are designed to comply with stringent international regulatory standards, including USFDA and WHO-GMP. Shivalik Rasayan's pharmaceutical portfolio includes critical oncology drugs such as Temozolomide, Bortezomib, and Azacitidine, which are supplied to global markets. Through its subsidiary, Medicamen Biotech, the company also extends its reach into finished dosage formulations, creating an integrated presence in the healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shivalik Rasayan.